Inspire Veterinary Partners, Inc.

IVPNASDAQConsumer Cyclical

$0.03

+$0.03(+1519.05%)

Market Cap$85826

P/E Ratio—

52W High$3.25

52W Low$0.0022

Avg Volume56.1M

Open$0.03

Beta-0.45

Free Cash Flow Financials Revenue

Inspire Veterinary Partners, Inc. (IVP) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

IVP · free cash flow · updated Jun 8, 2026

Core FCF metrics

IVP · FCF · TTM · margin & CAGR

Free cash flow was −$10.2M for FY2024 (fiscal year ending 2024-12-31), down 143.6% year-over-year The FCF margin was -61.7%.

FY2024 Free Cash Flow−$10.2M▼ -143.6% YoY

Trailing 12M (TTM)−$4.3Mtrailing 4 quarters sum

FCF Margin-61.7%−$10.2M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

IVP · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest−$10.0M(0M)−$10.2M▼ 143.6%-61.7%

FY2023−$3.8M(0M)−$4.2M▼ 48.3%-25.2%

FY2022−$2.7M(0M)−$2.8M▼ 22.2%-28.8%

FY2021−$1.0M(1M)−$2.3M▼ 41937.5%-91.0%

FY2020−$5,520(0M)−$5,520——

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

IVP · P/FCF · FCF yield · FCF per share

Inspire Veterinary Partners, Inc. (IVP) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

IVP · cash flow statement · operating / investing / financing

For FY2024, Inspire Veterinary Partners, Inc. generated −$10.0M in operating cash flow and spent 0M in capital expenditures, yielding −$10.2M in free cash flow.

Operating Activities

−$10.0M

Cash from core business operations

2024-12-31

Investing Activities

−$0.2M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

+$10.6M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF (−$10.0M) − |CapEx| (0M) = FCF (−$10.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Consumer Cyclical)

IVP vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Inspire Veterinary Partners, Inc.YOU

IVP

−$10.2M-143.6%-61.7%

Loss

Toyota Motor Corporation

Alibaba Group Holding Limited

BABA

−$50.72B-164.9%-5.0%

Loss

Consumer Cyclical · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Inspire Veterinary Partners, Inc. (IVP) reported free cash flow of −$10.2M for FY2024 (fiscal year ending 2024-12-31), down 143.6% year-over-year. The FCF margin was -61.7%.

Inspire Veterinary Partners, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 5 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

IVP free cash flow · 8 questions

Inspire Veterinary Partners, Inc. free cash flow was −$10.2M for FY2024, down 143.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$4.3M.

IVP free cash flowIVP FCFIVP FCF 2024IVP free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Inspire Veterinary Partners, Inc. · Inspire Veterinary Partners, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026